Dramatic Response of a PD-L1-Positive Advanced Angiosarcoma of the Scalp to Pembrolizumab

Related Experiment Video

Updated: Oct 4, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.7K

Rainer Hamacher1, Dietrich Kämpfe1, Kirsten Reuter-Jessen1

  • 1Rainer Hamacher, Martin Schuler, Sebastian Bauer, Christoph Pöttgen, Lars E. Podleska, Farhad Farzaliyev, and Hans-Ulrich Steinau, University Hospital Essen, University Duisburg-Essen; Martin Schuler and Sebastian Bauer, German Cancer Consortium, Partner Site University Hospital Essen, Essen; Dietrich Kämpfe, Hematology and Oncology Practice, Lüdenscheid; and Kirsten Reuter-Jessen and Hans-Ulrich Schildhaus, University Hospital Göttingen, Göttingen, Germany.

JCO Precision Oncology
|February 9, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.2K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

604

Related Concept Videos